Results 201 to 210 of about 78,261 (320)

The Real World Impact of Immunoglobulin Replacement Therapy on Severe Bacterial Infection for Patients With Hypogammaglobulinemia Secondary to Hematologic Malignancies: A Japanese Claims Database Study

open access: yeseJHaem, Volume 6, Issue 4, August 2025.
ABSTRACT Objectives The understanding of usefulness of immunoglobulin replacement therapy (IgRT) for hypogammaglobulinemia (HGG) in patients with hematologic malignancies (HM) has changed over time. This is mainly caused by the introduction of new treatment, such as B‐cell targeted agents.
Keichiro Mihara   +5 more
wiley   +1 more source

Paraneoplastic Syndromes in Gallbladder Cancer: A Systematic Review. [PDF]

open access: yesMedicina (Kaunas)
Lau BSR   +6 more
europepmc   +1 more source

LncRNA HOXB-AS3 promotes proliferation, migration, and invasion of gallbladder cancer cells by activating the MEK/ERK pathway

open access: yesHeliyon
Background: LncRNA HOXB-AS3 are associated with tumor progression in several types of carcinomas, yet, its possibly biological role in gallbladder carcinoma(GBC) remains unclear.
Jiayan Wu   +7 more
doaj  

Should suspected early gallbladder cancer be treated laproscopically?

open access: bronze, 2001
Steve T. Weiland   +5 more
openalex   +1 more source

Cardiac arrhythmias in cancer patients using the nationwide claim‐based database in Japan

open access: yesJournal of Arrhythmia, Volume 41, Issue 4, August 2025.
The prevalence of cancer increased with time in view of cardio‐oncology or oncocardiology, which has organically developed as a new discipline. The data showed similar patterns of distribution in patients with both arrhythmias and ischemic heart diseases. Abstract Background Cardio‐oncology has recently developed as a new discipline.
Takashi Kobayashi, Kengo Kusano
wiley   +1 more source

GLP‐1 receptor agonists and the risk for cancer: A meta‐analysis of randomized controlled trials

open access: yesDiabetes, Obesity and Metabolism, Volume 27, Issue 8, Page 4454-4468, August 2025.
Abstract Aims To assess if there is a difference in the oncogenic risk between GLP‐1 RA and comparators in randomized controlled trials. Materials and Methods A meta‐analysis of randomized controlled trials comparing GLP‐1RA to any comparators for diabetes and/or obesity, lasting at least 52 weeks.
Giovanni Antonio Silverii   +5 more
wiley   +1 more source

A CASE OF GALLBLADDER CANCER WITH A PSEUDOANEURYSM OF THE RIGHT HEPATIC ARTERY PRESENTED WITH BILIARY BLEEDING

open access: bronze, 2003
Hiroyuki Suzuki   +5 more
openalex   +2 more sources

Home - About - Disclaimer - Privacy